Loading clinical trials...
Loading clinical trials...
Phase I Clinical Study, to Evaluate the Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®, on the Ocular Surface of Clinically Healthy Subjects.
Conditions
Interventions
PRO 179
Travatan 0.004 % Ophthalmic Solution
Locations
1
Mexico
Jose Navarro Partida
Guadalajara, Jalisco, Mexico
Start Date
April 24, 2019
Primary Completion Date
July 2, 2019
Completion Date
August 29, 2019
Last Updated
December 12, 2019
NCT04354545
NCT07298356
NCT07396441
NCT06979752
NCT07390890
NCT07145073
Lead Sponsor
Laboratorios Sophia S.A de C.V.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions